Abstract
The aim of this work was to investigate the antibacterial activity of clove (Syzygium aromaticum) essential oil against multidrug resistant clinical strains of Klebsiella pneumoniae ESBL+. Materials: The antibacterial activity of the oil was tested against standard strain Klebsiella pneumoniae ATCC 700603 and 60 clinical strains of Klebsiella pneumoniae isolated from patients with infections of the respiratory tract, abdominal cavity, urinary tract, skin and from the hospital environment. Methods: The agar dilution method was used to assess the inhibition of microbial growth at various concentrations of the clove oil. Susceptibility testing to antibiotics was carried out using disc-diffusion. Results: The results of experiments showed that clove essential oil possessed very strong activity against all of the clinical strains of extendedspectrum β-lactamase (ESBL)-producing ESBL+ from Klebsiella pneumoniae. Conclusions: The results of this study suggest the potential use of clove essential oil against K. pneumoniae ESBL+ that is responsible for infections difficult to treat. Essential oils my be an excellent alternative for synthetic preparations and, used in combination with antibiotics, may prevent antibiotic-resistant strain development.
Keywords: Clove essential oil, ESBL+, K. pneumoniae, Minimal Inhibitory Concentration.
Anti-Infective Agents
Title:The Susceptibility of Klebsiella pneumoniae ESBL+ Strains to Clove (Syzygium aromaticum) Essential Oil
Volume: 11 Issue: 2
Author(s): Monika Sienkiewicz, Danuta Kalemba and Malgorzata Wasiela
Affiliation:
Keywords: Clove essential oil, ESBL+, K. pneumoniae, Minimal Inhibitory Concentration.
Abstract: The aim of this work was to investigate the antibacterial activity of clove (Syzygium aromaticum) essential oil against multidrug resistant clinical strains of Klebsiella pneumoniae ESBL+. Materials: The antibacterial activity of the oil was tested against standard strain Klebsiella pneumoniae ATCC 700603 and 60 clinical strains of Klebsiella pneumoniae isolated from patients with infections of the respiratory tract, abdominal cavity, urinary tract, skin and from the hospital environment. Methods: The agar dilution method was used to assess the inhibition of microbial growth at various concentrations of the clove oil. Susceptibility testing to antibiotics was carried out using disc-diffusion. Results: The results of experiments showed that clove essential oil possessed very strong activity against all of the clinical strains of extendedspectrum β-lactamase (ESBL)-producing ESBL+ from Klebsiella pneumoniae. Conclusions: The results of this study suggest the potential use of clove essential oil against K. pneumoniae ESBL+ that is responsible for infections difficult to treat. Essential oils my be an excellent alternative for synthetic preparations and, used in combination with antibiotics, may prevent antibiotic-resistant strain development.
Export Options
About this article
Cite this article as:
Sienkiewicz Monika, Kalemba Danuta and Wasiela Malgorzata, The Susceptibility of Klebsiella pneumoniae ESBL+ Strains to Clove (Syzygium aromaticum) Essential Oil, Anti-Infective Agents 2013; 11 (2) . https://dx.doi.org/10.2174/2211352511311020010
DOI https://dx.doi.org/10.2174/2211352511311020010 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Expression and Function of Angiomodulating Cytokines in Rheumatoid Arthritis and Experimental Arthritis: Important Therapeutic Targets
Current Immunology Reviews (Discontinued) Beneficial and Adverse Effects of Molecularly Targeted Therapies for Acute Promyelocytic Leukemia in Central Nervous System
CNS & Neurological Disorders - Drug Targets Cationic Polymers and their Self-Assembly for Antibacterial Applications
Current Topics in Medicinal Chemistry Ellipticines as DNA-Targeted Chemotherapeutics
Current Medicinal Chemistry Biological and Pharmacological Activities of Carvacrol and Carvacrol Bearing Essential Oils
Current Pharmaceutical Design MicroRNAs in Organogenesis and Disease
Current Molecular Medicine Modulation of Inflammatory Immune Reactions by Low-Dose Ionizing Radiation: Molecular Mechanisms and Clinical Application
Current Medicinal Chemistry Flt3 Receptor Tyrosine Kinase as a Drug Target in Leukemia
Current Pharmaceutical Design Antibody-Drug Conjugate Targets
Current Cancer Drug Targets Ribozyme- and Deoxyribozyme-Strategies for Medical Applications
Current Drug Targets Perinatal Gene Transfer to the Liver
Current Pharmaceutical Design Using Insights into Pim1 Structure to Design New Anticancer Drugs
Current Pharmaceutical Design DNA Methylation in the Pathogenesis of Systemic Lupus Erythematosus
Current Pharmacogenomics Microenvironmental Regulation of Cancer Stem Cell Phenotypes
Current Stem Cell Research & Therapy Amplification of Anticancer Drug-Induced DNA Damage and Apoptosis by DNA-Binding Compounds
Current Medicinal Chemistry - Anti-Cancer Agents A panoramic view of chronic liver diseases and natural remedies reported in Traditional Persian Medicine
Current Pharmaceutical Design Synthesis of Coumarin linked Naphthalimide Conjugates as Potential Anticancer and Antimicrobial Agents
Letters in Drug Design & Discovery HIV-1 Vectors: Fulfillment of Expectations, Further Advancements, and Still A Way To Go
Current HIV Research DNA Intercalators in Cancer Therapy: Organic and Inorganic Drugs and Their Spectroscopic Tools of Analysis
Mini-Reviews in Medicinal Chemistry Immunomodulatory Properties of Farnesoids: The New Steroids?
Current Medicinal Chemistry